The incidence of cervical cancer was reduced by nearly 90 per cent in British women who were vaccinated against the HPV infection that causes these cancers. According to a recently published study.
A vaccine against the human papillomavirus, or HPV, reduces the number of cervical cancer cases by 87 percent, according to a study published in scalpel. “Our study provides direct evidence of the effect of HPV vaccination, via the bivalent Cervarix vaccine, on cervical cancer,” the study authors said.
Cervical cancer is almost always caused by a sexually transmitted HPV infection. The success means that those who have been vaccinated will also need significantly fewer Pap smears, the researchers said.
According to the results of the study, there was a significant decrease in the number of cervical cancers in women eligible for the vaccination campaign in the United Kingdom, which began in the late 2000s. The incidence of cancer was 62 percent lower when the injections were given between the ages of 14 and 16 and 34 percent in women who were vaccinated between the ages of 16 and 18.
When the women who were vaccinated were around age 20, women who received the series of injections between ages 12 and 13 had 87 percent fewer cervical cancers than unvaccinated women who were screened for malignancy.
Several countries, including Belgium, have already started a campaign to encourage people to get vaccinated against this. The Flemish government offers the HPV vaccine free of charge to all girls and boys in the first year of secondary education.
“Total coffee specialist. Hardcore reader. Incurable music scholar. Web guru. Freelance troublemaker. Problem solver. Travel trailblazer.”